echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Illustration of the drug over-the-counter drug market license application technical guidance.

    Illustration of the drug over-the-counter drug market license application technical guidance.

    • Last Update: 2020-10-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Over-the-counter medicines have clear effectiveness, wide range of safety, low risk of misuse and abuse, determination of adaptive and usage usage, and are easy for people to judge, use and manage on their own.
    addition, over-the-counter drugs in dosage form, specifications, taste, color, odor, packaging and other aspects can better meet the personalized needs of the population.
    The Measures for the Administration of Drug Registration clearly stipulate that prescription drugs and over-the-counter drugs shall be subject to classification registration and conversion management, and if they meet one of the following conditions, they may directly apply for an over-the-counter drug listing license: (1) drugs that are already listed on the market with the same active ingredients, adaptive substances (or functional treatments), dosage forms and specifications within the territory; (2) Drugs that change dosage forms or specifications of over-the-counter drugs as determined by the State Drug Administration, but do not change the adaptation (or functional treatment), dosage and dosage methods of administration; (3) new compound preparations consisting of active ingredients of over-the-counter drugs determined by the State Drug Administration; and (4) other cases where over-the-counter drug listing permits are directly declared.
    based on the characteristics of China's over-the-counter drug registration and declaration, around the above four cases, the formulation of over-the-counter drug licensing applications for technical requirements.
    This guiding principle focuses on the overall consideration of the technical requirements involved in over-the-counter drug licensing applications, general principles and standards in research and development, such as the Drug Manufacturing Quality Management Practice (GMP), the Drug Clinical Trial Quality Management Practice (GCP), and the implementation of principles consistent with prescription drug listing licensing applications.
    rules are as follows:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.